Vital breakthrough as once-a-day pill can help people lose ‘significant’ weight
Once a day for obesity, the pill may be a cheaper and more accessible weight loss medication, after determining that the tablet may lead to “important” decreases in body weight.
More than 60 percent of adults living in the UK is obese or overweight – a crisis with an £ 107 billion per year for NHS.
However, researchers lost 20 percent of body weight after use for one and a half years.
Although weight loss seen in people who buy the tablet is not as sharp as among patients receiving Mounjaro, experts believe that the tablet will be more accessible and useful than the weight loss injections.
“Since this pill can be easier and cheaper to use, it can allow more people to access effective weight loss medications and make obesity treatment simpler and more suitable for patients everywhere, Dr.
Approximately 1.5 million people in the UK are receiving drugs such as Mounjaro, Özempic and Wegovy to deal with conditions such as obesity and diabetes.
Drugs known as GLP-1 agonists treat diabetes mainly, but are also available in NHS or through special providers to help adults with high body mass index. Drugs are mainly used to control blood sugar levels, but reduce food requests and as a result can cause rapid weight loss.
The Obasyon Pill is also a GLP-1 agonist made by Pharmaceutical Giant Lilly.
A instant image of the results was published by the company in August and published in a full article that details the findings. New England Medical Magazine and presented to the annual meeting of Austria’s Diabetes Research Association in Vienna.
The study divided the obesity of 3.127 participants into groups that took different powers of the weight loss pill, while others received a placebo for 72 weeks.
Patients from the United States, China, Brazil, India, Japan, South Korea, Spain, Slovakia and Taiwan participated in the study.
Researchers from McMaster University in Canada found that 72 weeks after 72 weeks, the lowest dose of 6mg or 5.5 percent of the body weights of people lost a 7.5 percent.
The highest dosage areas, a 36 mg tablet, lost an average of 11.2 percent of body weight.
Among the patients with the highest doses, 54.6 percent of people had a decrease in body weight by 10 percent, 36 percent decreased by 15 percent or more, and 18.4 percent decreased by 20 percent.
Better blood pressure, a smaller waist circumference and bad cholesterol levels had a decrease in medication. They reported that the most common side effects were “light to medium” gastrointestinal problems.
“In adults with obesity, 72 weeks of treatment in adults with obesity have led to a significant decrease in body weight than placebo. “The negative activity profile was consistent with the profile of other GLP-1 receptor agonists.”
Dr Sean Wharton, who leads the research, added: “This may mean that obesity interventions are expanded to groups excluded due to the cost and lack of access of injectable drugs.”
Weight loss jabs were greeted by health leaders as a transformative. However, injections come with additional studies for excessively stretched health services, so the tablet drug forms, which are expected to be cheaper and easier to use, can offer a new hope for millions of people who want to lose weight.
Eli Lilly said in August that Following the pressure of Donald Trump, who said that the overseas prices in US drugs want to comply with US costs, the drug price of the drug put up to 170 percent following the pressure.
The movement has already caused panic among many people who buy the drug, and long -term users are expected to be forced to get more than 100 £ more than £ each month at higher doses. However, the new pill is expected to be cheaper.
Dr Crystal Wyllie at ASDA online Dr. Dr Crystal Wyllie said: “It is much more appropriate for patients who struggle with needles and are easier to apply health services. Production costs can be cheaper to buy, store and carry forglpron, lower than injected drugs.”
